We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to ...

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Thermo Fisher (TMO – Research Report), with a price target ...

TMO continues to capture investors' attention due to its innovative product launches and trusted partnership status.

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Thermo Fisher Scientific, the world leader in serving science, today announced the introduction of Olink® Reveal, setting a ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to ...

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The global vaccine storage equipment market, valued at US$0.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$0.86 ...

Detailed price information for Netease Inc ADR (NTES-Q) from The Globe and Mail including charting and trades.

Among these, in 2023, the refrigerator segment accounted for the highest market share in the vaccine storage equipment market. This is owing to increasing ...

Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2024 results on Jan. 30, before market open. See the ...